Scleroderma’s reputation precedes itself.

Known as a skin disease, Scleroderma can negatively impact a person’s life if treatment is not sought.

The person’s quality of life will progressively deteriorate the longer this disease is left untreated.

The most severe stage of Scleroderma could eventually lead to death.

Sadly, a cure does not exist for this disease.

But, it can be controlled by Pulsed Electromagnetic Field (PEMF) therapy.

PEMF provides a way to control the symptoms of Scleroderma.

This noninvasive technique does not have any side effects.

Such a technique can offer those individuals who suffer from Scleroderma a viable option.

A viable option that will enhance their treatment protocol.

Scleroderma Defined

Literally, Scleroderma means “hard skin.”

Its name is commonly associated with a group of skin disorders.

The primary function of these skin disorders is to cause the tightening and hardening of connective tissues and the skin.

There are several types of Scleroderma.

But, the most prevalent ones are as follow:

• Limited Cutaneous Systemic Sclerosis
• Diffuse Systemic Sclerosis
• Systemic Scleroderma
• Localized Scleroderma

The nature of Scleroderma is ambiguous. Its intricacies are not completely known.

What is clear, however, is that this disease has a mild beginning that can erupt into a terrible ending.

Scleroderma is considered to be both a rheumatic and connective tissue disease by medical professionals.

Plus, its classification as an autoimmune disease exists because it is believed that our tissues are attacked by our own immune system.

Scleroderma’s Symptoms

Not everyone experiences the same symptoms.

They have a tendency to vary in pain level and location.

They range from moderate to severe pain.

And, they can have an effect on your body as a whole.

Or, they can affect various parts of your body.

Typically, the first symptoms include puffiness, tightness, and stiffness in your hands and fingers.

You may also experience swelling in your feet and hands during some mornings.

Other symptoms are associated with Scleroderma, including the following:

• Tightness and thickness of the fingers
• Esophageal complications
• Calcium deposits in the connective tissues
• Red spots on face and hands
• Blood vessel constriction in hands and feet (also known as Raynaud’s Disease)

Scleroderma’s Causes

Today, the exact cause of Scleroderma is still unknown.

However, its origin is believed to be caused by the body’s production of excessive collagen.

Such an overproduction of collagen leads to the previously mentioned symptoms.

It is also believed that other external and genetic factors contribute to the existence of this disease.

But, evidence to support this belief is still lacking.

The only 100 percent known fact about Scleroderma is that it is not contagious.

Scleroderma’s Treatments

Since the excessive production of collagen cannot be stopped, there is not a cure for Scleroderma.

However, an individual’s quality of life can be preserved by managing the collagen production level.

The idea is to slow down the collagen output level, which in turn will also slow down the symptoms and delay other complications.

Different types of Scleroderma can be treated with medications and some can be resolved on their own.

As such, a treatment protocol is specific to that individual.

Some treatments include the following: physical therapy, immunosuppressants, ultraviolet therapy, and blood pressure medications.

PEMF Therapy and Scleroderma

An alternative form of therapy is PEMF.

There should not be any expectations that PEMF will completely cure Scleroderma.

However, the development of this disease, as well as some of its complications and possible side effects, can be controlled by PEMF therapy.

In order to maximize its effects, PEMF should be used in conjunction with other approaches.

However, it can also be used alone.

Concrete evidence of the positive effects of PEMF on Scleroderma can be found in two studies that were conducted by a former John Hopkins Hospital doctor by the name of William Pawluk.

His first study consisted of 20 patients.

All of the patients had already been diagnosed with Scleroderma.

And, all of them were sufferers of Raynaud’s disease.

A stimulus was introduced at the C4Th7 and the Th10-L2 vertebrae in their spines.

The results indicated improvements in several areas of approximately 95 percent.

The areas with the highest improvement included the following:

• Reflexes
• Sweating
• Conduction of the ulnar nerve
• Sensitivity to coldness

Dr. Pawluk’s second study was performed differently.

This study required the usage of a different PEMF device.

And, in addition to this device, other more traditional approaches were used, like massages, supplements, and physical therapy.

This study consisted of 80 patients. Localized changes on their skin were seen in 52 of them.

And, changes occurred in multiple places for the remaining 28 patients.

The 80 patients were divided into two groups of 40 patients.

The first group was the basic group. The second group was the control group.

There was also a third group, which included only healthy participants.

Both the PEMF and traditional therapies were administered to the basic group.

The control group was administered only the traditional therapies.

The basic group received a total of 12 PEMF stimulations every other day.

The results were evaluated via immunological and clinical testing.

In the basic group, complete healing occurred in 16 patients, and significant improvement was shown by 22 patients.

Therefore, 95 percent of the patients demonstrated improvement to a certain degree.

In the control group, 10 patients demonstrated full recoveries, and significant improvement occurred in 22 patients.

Therefore, 73 percent of the patients demonstrated improvement to a certain degree.

Plus, the basic group demonstrated a significant improvement in lymphocyte blast and immunoglobulins transformation activity compared to the control group.

Such information led researchers to conclude that PEMF therapy should be taken more seriously in the fight against Scleroderma.

However, it should be noted that this research demonstrates the usage of only PEMF therapy in combination with other types of treatments.

Therefore, other research needs to be performed to ascertain if such outstanding results can also be achieved by using PEMF therapy by itself.

Conclusion

Scleroderma is a life-threatening disease that should be promptly addressed in its early stages.

It should not be ignored.

However, since its symptoms may not clearly present themselves quickly, then patients may be slow in their response to it.

PEMF therapy plays a vital role in the treatment of Scleroderma.

In a way, this therapy can be used as a preventative measure.

Plus, if the disease is fully developed, then PEMF therapy can be used to hinder its progression.

Or, at the very least, it can be used to slow down its progression.

As indicated in the studies, complete healing occurred as a result of PEMF therapy.

Dr. Pawluk’s research in this field is promising.

It proves that PEMF therapy and Scleroderma are connected in such a way that causes patients to seek out the best course of treatment to help them regain a normal standard of health.